Endothelin-A receptor blockade and inhaled nitric oxide in a porcine model of meconium aspiration syndrome

Pediatric Research

Volumn 56, Issue 3, 2004, Pages 353-358

  Shekerdemian, Lara S ^a   Penny, Daniel J ^a   Ryhammer, Pia K ^b   Reader, Jayne A ^c   Ravn, Hanne B ^b  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; FEMALE; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MECONIUM ASPIRATION; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION; SWINE; VASODILATATION;

EID: 4344612637     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.PDR.0000134257.20214.57     Document Type: Article

References (43)

1. Kinsella JP, Abman SH 1995 Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newborn. J Pediatr 126:853-864
2. Coltart TM, Byrne DL, Bates SA 1989 Meconium aspiration syndrome: a 6-year retrospective study. Br J Obstet Gynaecol 96:411-414
3. Christou H, Adatia I, Van Marter LJ, Kane JW, Thompson JE, Stark AR, Wessel DL, Kourembanas S 1997 Effect of inhaled nitric oxide on endothelin-1 and cyclic guanosine 5′-monophosphate plasma concentrations in newborn infants with persistent pulmonary hypertension. J Pediatr 130:603-611
4. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T 1988 A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415
5. Ivy DD, Kinsella JP, Abman SH 1994 Physiologic characterization of endothelin A and B receptor activity in the ovine fetal pulmonary circulation. J Clin Invest 93:2141-2148
6. Malamitsi-Puchner A, Economou E, Sevastiadou S, Efstathopoulos T, Nicolopoulos D 1993 Endothelin 1-21 plasma levels on the first and fourth postpartum day in normal full-term neonates. Dev Pharmacol Ther 20:195-198
7. Kuo C, Chen J 1999 Effect of meconium aspiration on plasma endothelin-1 level and pulmonary hemodynamics in a piglet model. Biol Neonate 76:228-234
8. Rosenberg AA, Kennaugh J, Koppenhafer SL, Loomis M, Chatfield BA, Abman SH 1993 Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension. J Pediatr 123:109-114
9. Kumar P, Kazzi NJ, Shankaran S 1996 Plasma immunoreactive endothelin-1 concentrations in infants with persistent pulmonary hypertension of the newborn. Am J Perinatol 13:335-341
10. Ishikawa S, Miyauchi T, Sakai S, Ushinohama H, Sagawa K, Fusazaki N, Kado H, Sunagawa H, Honda S, Ueno H, Yamaguchi I, Sugishita Y, Goto K 1995 Elevated levels of plasma endothelin-1 in young patients with pulmonary hypertension caused by congenital heart disease are decreased after successful surgical repair. J Thorac Cardiovasc Surg 110:271-273
11. Cody RJ, Haas GJ, Binkley PF, Capers Q, Kelley R 1992 Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation 85:504-509
12. Pousset F, Isnard R, Lechat P, Kalotka H, Carayon A, Maistre G, Escolano S, Thomas D, Komajda M 1997 Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur Heart J 18:254-258
13. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, Kinsella JP 2000 Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 342:469-474
14. Mercier JC, Lacaze T, Storme L, Roze JC, Dinh-Xuan AT, Dehan M 1998 Disease-related response to inhaled nitric oxide in newborns with severe hypoxaemic respiratory failure. French Paediatric Study Group of Inhaled NO. Eur J Pediatr 157:747-752
15. Schulze-Neick I, Li J, Reader JA, Shekerdemian L, Redington AN, Penny DJ 2002 The endothelin antagonist BQ123 reduces pulmonary vascular resistance after surgical intervention for congenital heart disease. J Thorac Cardiovasc Surg 124:435-441
16. Coe Y, Haleen SJ, Welch KM, Liu YA, Coceani F 2002 The endothelin A receptor antagonists PD 156707 (CI-1020) and PD 180988 (CI-1034) reverse the hypoxic pulmonary vasoconstriction in the perinatal lamb. J Pharmacol Exp Ther 302:672-680
17. Coe Y, Haleen SJ, Welch KM, Coceani F 2000 The endothelin-A-receptor antagonist PD 180988 (CI-1034) selectively reverses the pulmonary vasoconstrictor response to hypoxia in the lamb. J Cardiovasc Pharmacol 36:S331-333
18. Perreault T, Berkenbosch JW, Barrington KJ, Decker ER, Wu C, Brock TA, Baribeau J 2001 TBC3711, an ET(A) receptor antagonist, reduces neonatal hypoxia-induced pulmonary hypertension in piglets. Pediatr Res 50:374-383
19. Thebaud B, de Lagausie P, Forgues D, Aigrain Y, Mercier JC, Dinh-Xuan AT 2000 ET(A)-receptor blockade and ET(B)-receptor stimulation in experimental congenital diaphragmatic hernia. Am J Physiol Lung Cell Mol Physiol 278:L923-L932
20. Prie S, Stewart DJ, Dupuis J 1998 Endothelin A receptor blockade improves nitric oxide-mediated vasodilation in monocrotaline-induced pulmonary hypertension. Circulation 97:2169-2174
21. Wedgwood S, McMullan DM, Bekker JM, Fineman JR, Black SM 2001 Role for endothelin-1-induced superoxide and peroxynitrite production in rebound pulmonary hypertension associated with inhaled nitric oxide therapy. Circ Res 89:357-364
22. Shekerdemian LS, Ravn HB, Penny DJ 2002 Intravenous sildenafil lowers pulmonary vascular resistance in a model of neonatal pulmonary hypertension. Am J Respir Crit Care Med 165:1098-1102
23. Channick RN, Rubin LJ 2001 New and experimental therapies for pulmonary hypertension. Clin Chest Med 22:539-545
24. Higenbottam TW, Laude EA 1998 Endothelial dysfunction providing the basis for the treatment of pulmonary hypertension: Giles F. Filley lecture. Chest 114:72S-79S
25. Oparil S, Chen SJ, Meng QC, Elton TS, Yano M, Chen YF 1995 Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat. Am J Physiol 268:L95-L100
26. Kuo CY 2001 Endothelin-A receptor antagonist prevents neonatal pulmonary hypertension in meconium aspiration in piglets. J Formos Med Assoc 100:420-423
27. Holm P, Liska J, Franco-Cereceda A 1998 The ETA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo. Cardiovasc Res 37:765-771
28. Wang L, Zhu du M, Su X, Bai CX, Ware LB, Matthay MA 2004 Acute cardiopulmonary effects of a dual-endothelin receptor antagonist on oleic acid-induced pulmonary arterial hypertension in dogs. Exp Lung Res 30:31-42
29. Ambalavanan N, Philips JB, 3rd, Bulger A, Oparil S, Chen YF 2002 Endothelin-A receptor blockade in porcine pulmonary hypertension. Pediatr Res 52:913-921
30. Truog WE, Pallotto E, Clark P, Banks B, Kaftan HA, Ekekezie II, Norberg M, Ballard RA 2002 Interaction of endogenous endothelin-1 and inhaled nitric oxide in term and preterm infants. Clin Sci (Lond) 103:294S-297S
31. McMullan DM, Bekker JM, Johengen MJ, Hendricks-Munoz K, Gerrets R, Black SM, Fineman JR 2001 Inhaled nitric oxide-induced rebound pulmonary hypertension: role for endothelin-1. Am J Physiol Heart Circ Physiol. 280:H777-H785
32. Pearl JM, Nelson DP, Raake JL, Manning PB, Schwartz SM, Koons L, Shanley TP, Wong HR, Duffy JY 2002 Inhaled nitric oxide increases endothelin-1 levels: a potential cause of rebound pulmonary hypertension. Crit Care Med 30:89-93
33. Chen L, He H, Fernandez Mondejar E, Freden F, Wiklund P, Alving K, Hedenstiema G 2001 Endothelin-I and nitric oxide synthase in short rebound reaction to short exposure to inhaled nitric oxide. Am J Physiol Heart Circ Physiol. 281:H124-H131
34. Junbao D, Jianfeng J, Wanzhen L, Bin Z, Heping Z 1999 Nitric oxide impacts endothelin-1 gene expression in intrapulmonary arteries of chronically hypoxic rats. Angiology 50:479-485
35. Goligorsky MS, Tsukahara H, Magazine H, Andersen TT, Malik AB, Bahou WF 1994 Termination of endothelin signaling: role of nitric oxide. J Cell Physiol 158:485-494
36. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, Pulido T, Frost A, Roux S, Leconte I, Landzberg M, Simonneau G 2002 Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346:896-903
37. Channick RN, Simonneau G, Sithon O, Robbins IM, Frost A, Tapson VF, Badesch DB, Roux S, Rainisio M, Bodin F, Rubin LJ 2001 Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study. Lancet 358:1119-1123
38. Barst RJ, Ivy D, Dingemanse J, Widlitz A, Schmitt K, Doran A, Bingaman D, Nguyen N, Gaitonde M, van Giersbergen PL 2003 Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension. Clin Pharmacol Ther 73:372-382
39. Cirino M, Martin E, Yano M, Rodger IW 1997 Cardiovascular and renal actions of the endothelin(B) receptor in pigs. J Cardiovasc Pharmacol 29:704-712
40. Fineman JR, Wong J, Mikhailov T, Vanderford PA, Jerome HE, Soifer SJ 1999 Altered endothelial function in lambs with pulmonary hypertension and acute lung injury. Pediatr Pulmonol 27:147-156
41. Ichinose F, Erana-Garcia J, Hromi J, Raveh Y, Jones R, Krim L, Clark MW, Winkler JD, Bloch KD, Zapol WM 2001 Nebulized sildenafil is a selective pulmonary vasodilator in lambs with acute pulmonary hypertension. Crit Care Med 29:1000-1005
42. Chappell SE, Wolfson MR, Shaffer TH 2001 A comparison of surfactant delivery with conventional mechanical ventilation and partial liquid ventilation in meconium aspiration injury. Respir Med 95:612-617
43. Hachey WE, Eyal FG, Curtet-Eyal NL, Kellum FE 1998 High-frequency oscillatory ventilation versus conventional ventilation in a piglet model of early meconium aspiration. Crit Care Med 26:556-561